Home › Funds › Kiltearn Partners LLP › GILD

Kiltearn Partners LLP position in GILD

GILEAD SCIENCES INC · Health Care

Kiltearn Partners LLP reported holding 90,733 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$13.5M, representing 3.25% of its reported portfolio and ranking #10 among its reported holdings. Kiltearn Partners LLP has disclosed GILD holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)90.73K sh
Reported value held$13.52M
Portfolio Weight3.25%
First reportedQ3 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Kiltearn Partners LLP's GILD position evolved

Kiltearn Partners LLP first disclosed a stake in GILD in Q3 2024 at 72,600 shares (US$6.1M). The position peaked in Q1 2025 at 146,000 shares, worth US$16.4M. Across 9 filings, Kiltearn Partners LLP increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 90,733 shares valued at US$13.5M — a reduction of -4,138 shares quarter over quarter.. Notable position changes include a 108% increase in Q4 2024 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 72.60K $6.09M New
Q4 2024 150.90K $13.94M Add
Q1 2025 146.00K $16.36M Reduce
Q2 2025 134.40K $14.90M Reduce
Q3 2025 145.80K $16.18M Add
Q4 2025 121.30K $14.89M Reduce
Q1 2026 100.40K $13.99M Reduce
Q2 2026 94.87K $11.99M Reduce
Q3 2026 90.73K $13.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Kiltearn Partners LLP held GILD?

Kiltearn Partners LLP has disclosed GILD holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Kiltearn Partners LLP's current position in GILD?

As of Q3 2026, Kiltearn Partners LLP holds 90.73K shares of GILD (GILEAD SCIENCES INC), valued at $13.52M, representing 3.25% of its reported portfolio and ranking #10.

Has Kiltearn Partners LLP been buying or selling GILD?

In the latest 13F filing (Q3 2026), Kiltearn Partners LLP reduced its position in GILD. The position peaked in Q1 2025 at 146.00K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.